Neurocrine Biosciences (NBIX) Lags Q2 Earnings Estimates

Neurocrine Biosciences (NBIX) came out with quarterly earnings of $0.63 per share, missing the Zacks Consensus Estimate of$ 1.15 per share. This compares to earnings of $0.95 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -45.22%. A quarter ago, it was expected that this biopharmaceutical company would post earnings of$ 1.04 per share when it actually produced earnings of $0.42, delivering a surprise of -59.62%. Over the las ...